+Search query
-Structure paper
Title | An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin. |
---|---|
Journal, issue, pages | Cancer Res., Vol. 73, Page 6024-6035, Year 2013 |
Publish date | Mar 15, 2014 (structure data deposition date) |
Authors | Garner, A.P. / Bialucha, C.U. / Sprague, E.R. / Garrett, J.T. / Sheng, Q. / Li, S. / Sineshchekova, O. / Saxena, P. / Sutton, C.R. / Chen, D. ...Garner, A.P. / Bialucha, C.U. / Sprague, E.R. / Garrett, J.T. / Sheng, Q. / Li, S. / Sineshchekova, O. / Saxena, P. / Sutton, C.R. / Chen, D. / Chen, Y. / Wang, H. / Liang, J. / Das, R. / Mosher, R. / Gu, J. / Huang, A. / Haubst, N. / Zehetmeier, C. / Haberl, M. / Elis, W. / Kunz, C. / Heidt, A.B. / Herlihy, K. / Murtie, J. / Schuller, A. / Arteaga, C.L. / Sellers, W.R. / Ettenberg, S.A. |
External links | Cancer Res. / PubMed:23928993 |
Methods | X-ray diffraction |
Resolution | 3.4 Å |
Structure data | PDB-4p59: |
Chemicals | ChemComp-NAG: ChemComp-HOH: |
Source |
|
Keywords | Signaling protein / immune system / Her3 receptor / therapeutic antibody / Fab fragment / anti-Her3 |